PH24069A - Process for the preparation of morphologically homogeneous forms of thiazole derivatives - Google Patents

Process for the preparation of morphologically homogeneous forms of thiazole derivatives

Info

Publication number
PH24069A
PH24069A PH35602A PH35602A PH24069A PH 24069 A PH24069 A PH 24069A PH 35602 A PH35602 A PH 35602A PH 35602 A PH35602 A PH 35602A PH 24069 A PH24069 A PH 24069A
Authority
PH
Philippines
Prior art keywords
preparation
thiazole derivatives
homogeneous forms
morphologically homogeneous
morphologically
Prior art date
Application number
PH35602A
Other languages
English (en)
Inventor
Peter Bod
Kalman Harsanyi
Hela Hegedus
Erik Bogsch
Eva Fekecs
Imre Peter
Zsuzsanna Aracs-Nee-Trischler
Sandor Miszori
Maria Stiller
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10963778&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH24069(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of PH24069A publication Critical patent/PH24069A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH35602A 1986-08-05 1987-07-30 Process for the preparation of morphologically homogeneous forms of thiazole derivatives PH24069A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU863370A HU196775B (en) 1986-08-05 1986-08-05 Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances

Publications (1)

Publication Number Publication Date
PH24069A true PH24069A (en) 1990-03-05

Family

ID=10963778

Family Applications (1)

Application Number Title Priority Date Filing Date
PH35602A PH24069A (en) 1986-08-05 1987-07-30 Process for the preparation of morphologically homogeneous forms of thiazole derivatives

Country Status (18)

Country Link
US (3) US4894459A (fr)
EP (1) EP0256747B2 (fr)
JP (2) JP2644234B2 (fr)
KR (1) KR940003954B1 (fr)
CN (1) CN1024275C (fr)
AR (1) AR243175A1 (fr)
AT (1) ATE82274T1 (fr)
AU (1) AU604040B2 (fr)
BG (1) BG60496B2 (fr)
CA (1) CA1265809A (fr)
CS (1) CS268188B2 (fr)
DE (2) DE256747T1 (fr)
DK (1) DK175022B1 (fr)
FI (1) FI89917C (fr)
GR (1) GR871216B (fr)
HU (1) HU196775B (fr)
PH (1) PH24069A (fr)
PT (1) PT85473B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO882037L (no) * 1987-06-22 1988-12-23 Marga Para La Investigacion Sa Famotidin, polymerte former og fremstilling derav.
ATE208615T1 (de) * 1993-07-09 2001-11-15 Scherer Corp R P Verfahren zur herstellung von gefriergetrockneten arzneistoffdosierungsformen
US6939873B2 (en) * 2000-07-26 2005-09-06 Taro Pharmaceuticals Industries Limited Non-sedating barbituric acid derivatives
US7683071B2 (en) * 2000-07-26 2010-03-23 Taro Pharmaceuticals Industries Ltd. Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid
US6756379B2 (en) * 2001-07-26 2004-06-29 Taro Pharmaceutical Industries Ltd. Non-sedating barbiturate compounds as neuroprotective agents
TWI353979B (en) * 2002-04-10 2011-12-11 Nippon Zoki Pharmaceutical Co Novel crystal form of 5-hydroxy-1-methylhydantoin
CA2426122A1 (fr) * 2002-05-02 2003-11-02 M/S Tonira Pharma Limited Methode de preparation d'un melange de polymorphes a et b de la famotidine
TW200409746A (en) * 2002-07-26 2004-06-16 Theravance Inc Crystalline β2 adrenergic receptor agonist
AR042444A1 (es) 2002-12-11 2005-06-22 Taro Pharmaceuticals Ireland L Metodo para el tratamiento de desordenes del movimiento mediante la utilizacion de acido barbiturico
TW200510277A (en) * 2003-05-27 2005-03-16 Theravance Inc Crystalline form of β2-adrenergic receptor agonist
EP1781624A4 (fr) * 2004-07-02 2010-06-23 Taro Pharma Ind Procede de preparation d'acide 1-methoxymethyl-5,5-diphenylbarbiturique
EP1919288A4 (fr) * 2005-07-18 2009-12-16 Horizon Therapeutics Inc Medicaments contenant famotidine et ibuprofene, et administration desdits medicaments
US20080021078A1 (en) * 2006-07-18 2008-01-24 Horizon Therapeutics, Inc. Methods and medicaments for administration of ibuprofen
US8067451B2 (en) * 2006-07-18 2011-11-29 Horizon Pharma Usa, Inc. Methods and medicaments for administration of ibuprofen
US20080020040A1 (en) * 2006-07-18 2008-01-24 Horizon Therapeutics, Inc. Unit dose form for administration of ibuprofen
US8067033B2 (en) 2007-11-30 2011-11-29 Horizon Pharma Usa, Inc. Stable compositions of famotidine and ibuprofen
WO2008011426A2 (fr) 2006-07-18 2008-01-24 Horizon Therapeutics, Inc. Procédés et médicaments destinés à l'administration d'ibuprofène
WO2008027963A2 (fr) * 2006-08-31 2008-03-06 Horizon Therapeutics, Inc. Formulations à dose unique d'ains avec antagonistes du récepteur de h2, et procédés d'utilisation
US7718649B1 (en) 2006-11-10 2010-05-18 Pisgah Labs, Inc. Physical states of a pharmaceutical drug substance
US8039461B1 (en) 2006-11-10 2011-10-18 Pisgah Laboratories, Inc. Physical states of a pharmaceutical drug substance
EP2081576A4 (fr) * 2006-11-14 2010-06-30 Taro Pharmaceuticals North Ame Procédé d'amélioration de la biodisponibilité pour les barbituriques non sédatifs
US8883863B1 (en) 2008-04-03 2014-11-11 Pisgah Laboratories, Inc. Safety of psuedoephedrine drug products
TW201011043A (en) * 2008-06-20 2010-03-16 Chugai Pharmaceutical Co Ltd Crystal of spiroketal derivatives and process for preparation of spiroketal derivatives
WO2015163832A1 (fr) 2014-04-25 2015-10-29 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. Composition combinée d'ibuprofène et de famotidine ayant une stabilité améliorée
TR201618765A2 (tr) 2016-12-16 2018-07-23 Imuneks Farma Ilac Sanayi Ve Ticaret Anonim Sirketi Ağrı ve enflamasyonun tedavisi için steroid olmayan anti-enflamatuvar ilaçlar ve H2 reseptörü antagonisti kombinasyonları.
US11331307B2 (en) 2020-07-15 2022-05-17 Schabar Research Associates, Llc Unit oral dose compositions composed of ibuprofen and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1543238A (en) * 1976-09-21 1979-03-28 Smith Kline French Lab Polymorph of cimetidine
JPS6056143B2 (ja) * 1979-08-02 1985-12-09 山之内製薬株式会社 アミジン誘導体ならびにその製造法
JPS5655383A (en) * 1979-10-12 1981-05-15 Yamanouchi Pharmaceut Co Ltd Amizine derivative and its preparation
HU185457B (en) * 1981-09-25 1985-02-28 Richter Gedeon Vegyeszet Process for preparating cimetidine-z
US4496737A (en) * 1982-09-27 1985-01-29 Merck & Co., Inc. Process for preparing sulfamylamidine antisecretory agents
JPS59227870A (ja) * 1983-06-07 1984-12-21 Yamanouchi Pharmaceut Co Ltd 新規２−グアニジノチアゾリン誘導体ならびにその製造法
HU194845B (en) * 1985-09-11 1988-03-28 Richter Gedeon Vegyeszet Process for production of n-sulphamil-3-/2-guanidintiazolil-4-methil-tio/-propion-amidin
DE3644246A1 (de) * 1986-06-20 1987-12-23 Uriach & Cia Sa J Verfahren zur herstelung von 3-(((2-((aminoiminomethyl)-amino)-4-thiazolyl)-methyl)-thio)-n-(aminosulfonyl)-propanimidamid
GB8618847D0 (en) * 1986-08-01 1986-09-10 Smith Kline French Lab Pharmaceutical formulations
NO882037L (no) * 1987-06-22 1988-12-23 Marga Para La Investigacion Sa Famotidin, polymerte former og fremstilling derav.

Also Published As

Publication number Publication date
JPS6399065A (ja) 1988-04-30
FI873346A0 (fi) 1987-08-03
ATE82274T1 (de) 1992-11-15
CS268188B2 (en) 1990-03-14
EP0256747B2 (fr) 2001-11-28
GR871216B (en) 1987-11-19
DK404187A (da) 1988-02-06
FI89917B (fi) 1993-08-31
US5120850A (en) 1992-06-09
DK175022B1 (da) 2004-04-26
DE3782576D1 (de) 1992-12-17
US4894459A (en) 1990-01-16
CN1024275C (zh) 1994-04-20
AR243175A1 (es) 1993-07-30
HUT45240A (en) 1988-06-28
DE256747T1 (de) 1988-11-24
PT85473A (en) 1987-09-01
EP0256747B1 (fr) 1992-11-11
HU196775B (en) 1989-01-30
BG60496B2 (bg) 1995-05-31
JP2644234B2 (ja) 1997-08-25
CN87105373A (zh) 1988-06-08
KR880002847A (ko) 1988-05-11
KR940003954B1 (ko) 1994-05-09
JP2708715B2 (ja) 1998-02-04
FI89917C (fi) 1993-12-10
PT85473B (pt) 1990-06-29
AU604040B2 (en) 1990-12-06
DK404187D0 (da) 1987-08-03
DE3782576T2 (de) 1993-03-25
EP0256747A1 (fr) 1988-02-24
DE3782576T3 (de) 2002-08-08
AU7654287A (en) 1988-02-11
US5128477A (en) 1992-07-07
JPH07316141A (ja) 1995-12-05
FI873346A (fi) 1988-02-06
CA1265809A (fr) 1990-02-13
CS579987A2 (en) 1989-04-14

Similar Documents

Publication Publication Date Title
GR871216B (en) Process for the preparation of morphologically homogeneous forms of thiazole derivatives
HU906232D0 (en) Process for the preparation of pyridile derivatives
PT84938A (en) Process for the preparation of imidazoquinolinylether derivatives
HU895305D0 (en) Process for the preparation of piperidinyl-benzimidazole derivatives
GR870220B (en) Process for the preparation of dichloroaniline derivatives
GB2203146B (en) Thiazole derivatives
AR243194A1 (es) Un procedimiento para la preparacion de derivados de ergolina 2-halogenados
HU895410D0 (en) Process for the preparation of quinolyl-oxazol-2-on derivatives
EP0335524A3 (en) Process for the preparation of indigo compounds
HU896472D0 (en) Process for the preparation of novel benzopyramylpyrrolinone derivatives
HU895959D0 (en) Process for the preparation of substituted oxa-diaminebutane derivatives
IL85706A0 (en) Process for the preparation of nitroethene derivatives
EP0330419A3 (en) Process for the preparation of indigo compound
PT85153A (en) Process for the preparation of benzimidazol derivatives
PT86176A (en) Process for the preparation of 12-halogenated forskolin derivatives
HU901556D0 (en) Process for the preparation of tetrahydronaphthalene derivatives
PT84100A (en) Process for the preparation of fluorinated diaminoalkyne derivatives
PT84853A (en) Process for preparing thiazinone derivatives
HU896159D0 (en) Process for the preparation of novel thiazolidinone derivatives
ZA894833B (en) Process for the preparation of homonojirimycin derivatives
EP0258855A3 (en) Process for the preparation of aminothiophene derivatives
EP0368508A3 (en) Process for the preparation of indigo compounds
PT82624A (en) Process for the preparation of azol derivatives
YU204987A (en) Process for obtaining derivatives of 2-guanadinothiazole
HU882836D0 (en) Process for the preparation of thiazolidinedione derivatives